Recombinant Human IL4R Protein (Gly24-His232), C-6×His-tagged
Product Description
Cat
IMP-10468
Official Symbol
IL4R
Product Overview
Recombinant human IL-4R alpha protein (Gly24-His232) with C-terminal 6×His tag was expressed in Chinese Hamster Ovary cell line.
Description
This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE production. The encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. Polymorphisms in this gene are also associated with resistance to human immunodeficiency virus type-1 infection. Alternate splicing results in multiple transcript variants.
Expression System
CHO
Species
Human
Tag
C-6×His
Predicted N Terminal
Gly24
Form
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Molecular Mass
Predicted Molecular Mass: 25 kDa
SDS-PAGE: 49-58 kDa, under reducing conditions.
Protein length
Gly24-His232
Bio-activity
Measured by its ability to inhibit IL-4-dependent proliferation of TF-1 human erythroleukemic cells. Approximately 3.00-20.0 ng/mL of IL-4 R alpha will inhibit 50% of the biological response due to 0.2 ng/mL of recombinant human IL-4.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 500 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Bioactivity

Measured by its ability to inhibit IL-4-dependent proliferation of TF-1 human erythroleukemic cells. Approximately 3.00-20.0 ng/mL of IL-4 R alpha will inhibit 50% of the biological response due to 0.2 ng/mL of recombinant human IL-4.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info